Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
1 - 20 of 39 results
Applied Filters
必威体育登录手机In this technical overview, we embedded a single HT-1080 tumor spheroid into extracellular matrix, using the 3D spheroid invasion module of the Agilent xCELLigence RTCA eSight system to continuously acquire brightfield and fluorescent channel images...
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
Using real-time cell potency and bioenergetic assays to optimize critical process parameters for manufacturing of engineered T cells.
Using real-time cell potency and bioenergetic assays to optimize critical process parameters for manufacturing of engineered T cells with eSight and Seahorse technology.
This application note demonstrates the signal recording of the xCELLigence RTCA eSight, enabling visualization and quantification of cell migration and invasion and the speed of wound closure healing.
This application note describes a novel real-time co-culture assay using RTCA eSight for interrogating NK92 immune cell invasion and cytotoxicity and migratory kinetic profiles based on ECM and effects of TME.
必威体育登录手机The Agilent xCELLigence RTCA DP system expands the throughput and application options xCELLigence Real-Time Cell Analysis (RTCA) portfolio featuring a dual-purpose (DP) format.
必威体育登录手机Integrating the Agilent xCELLigence Real Time Cell Analyzer (RTCA) HT instrument with the Agilent BioTek BioSpa 8 automated incubator expands the screening throughput of your RTCA HT instrument.
Multiparametric real-time automated readouts using simultaneous cellular impedance and live cell imaging.
必威体育登录手机Technical overview describes a method for monoclonal cell isolation using a live cell analysis system, the Agilent xCELLigence RTCA eSight, with a limiting dilution cloning method.
必威体育登录手机The Agilent xCELLigence Real-Time Cell Analysis (RTCA) Software Pro is an integrated software package to generate and analyze data obtained from xCELLigence RTCA DP, SP, MP, S16, and HT instruments.
必威体育登录手机This application note evaluates the Agilent xCELLigence RTCA eSight as a tool to monitor BiTE antibody-mediated cancer cell lysis.
The xCELLigence RTCA S16 system uses biosensors to continuously monitor live cell proliferation, morphological changes, and attachment quality in a label-free and real-time manner.
The eSight platform provides an efficient way to dynamically monitor immune cell activation and clustering to advance tumor immunotherapy development.Here, we evaluate CAR-T and NK92 cell killing efficacy.
必威体育登录手机Agilent xCELLigence Real-Time Cell Analyzer HT-Biotek BioSpa 8 specifications data sheet.
必威体育登录手机Agilent xCELLigence RTCA S16 System Data Sheet.
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
必威体育登录手机How-to guide detailing how to download, install, and register the Agilent xCELLigence RTCA Software Pro version 2.8.1.This guide is relevant to new and existing users.
Quick reference guide to calculate percent cytolysis for xCELLigence RTCA eSight users with an active Immunotherapy license.
Poster from SOT 2024.必威体育登录手机Drug safety testing can be optimized using HUREL micro livers on two Agilent cell analysis platforms: Seahorse XF Pro and xCELLigence RTCA Analyzer.